In the lesional skin tissues and fibroblasts from human systemic sclerosis (SSc) patients, the expression of PPARγ was decreased, further study confirmed that TGF-β treatment contributed to its diminished expression [49]. The gene discussed is TGFB1; the disease is systemic sclerosis.